FDA Device Registration & Listing · Sunnyvale, CA, US · Registration 3004530258
Normalized identity and public registration information from FDA records.
| Product Code | Device Name | Medical Specialty | Device Class | Regulation Number | Created Date |
|---|---|---|---|---|---|
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2024-12-11 |
| POC | System, Nucleic Acid Amplification Test, Dna, Antimicrobial Resistance Marker, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2024-12-11 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2019-12-14 |
| NJR | Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test | Microbiology | Class 1 | 866.3740 | 2004-04-13 |
| NPR | Test, Factor Ii G20210a Mutations, Genomic Dna Pcr | Hematology | Class 2 | 864.7280 | 2023-04-05 |
| NPQ | Test, Factor V Leiden Mutations, Genomic Dna Pcr | Hematology | Class 2 | 864.7280 | 2023-04-05 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2023-04-05 |
| PEU | System, Nucleic Acid-Based, Mycobacterium Tuberculosis Complex, Resistance Marker, Direct Specimen | Microbiology | Class 2 | 866.3373 | 2020-03-04 |
| JJH | Clinical Sample Concentrator | Clinical Chemistry | Class 1 | 862.2310 | 2024-12-12 |
| PCH | Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System | Microbiology | Class 2 | 866.3990 | 2026-01-28 |
| NQX | System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2013-11-13 |
| NPR | Test, Factor Ii G20210a Mutations, Genomic Dna Pcr | Hematology | Class 2 | 864.7280 | 2024-12-11 |
| LSL | Dna-Reagents, Neisseria | Microbiology | Class 2 | 866.3390 | 2020-03-04 |
| NQX | System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2015-06-04 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2009-11-20 |
| NPQ | Test, Factor V Leiden Mutations, Genomic Dna Pcr | Hematology | Class 2 | 864.7280 | 2009-11-20 |
| NPR | Test, Factor Ii G20210a Mutations, Genomic Dna Pcr | Hematology | Class 2 | 864.7280 | 2009-11-20 |
| MKZ | Dna Probe, Nucleic Acid Amplification, Chlamydia | Microbiology | Class 1 | 866.3120 | 2020-03-04 |
| NJR | Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test | Microbiology | Class 1 | 866.3740 | 2004-04-13 |
| OMN | C. Difficile Nucleic Acid Amplification Test Assay | Microbiology | Class 1 | 866.2660 | 2011-12-01 |
| OCC | Respiratory Virus Panel Nucleic Acid Assay System | Microbiology | Class 2 | 866.3980 | 2024-12-10 |
| QQX | Respiratory Specimen Nucleic Acid Sars-Cov-2 Test | Microbiology | Class 2 | 866.3981 | 2025-02-20 |
| OHQ | Multi-Analyte Controls Unassayed | Clinical Chemistry | Class 1 | 862.1660 | 2012-12-11 |
| OAI | Assay, Enterovirus Nucleic Acid | Microbiology | Class 2 | 866.3225 | 2007-06-08 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2022-09-09 |
| PGX | Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System | Microbiology | Class 2 | 866.2680 | 2022-09-09 |
| OYX | Bcr/Abl1 Monitoring Test | Medical Genetics | Class 2 | 866.6060 | 2014-05-09 |
| NQX | System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2024-12-11 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2024-12-11 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2018-01-16 |
| PMY | System, Nucleic Acid Amplification Test, Dna, Carbapenem Non-Susceptible Gram Negative Organism, Colony | Microbiology | Class 2 | 866.1640 | 2018-01-16 |
| POC | System, Nucleic Acid Amplification Test, Dna, Antimicrobial Resistance Marker, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2018-01-16 |
| OCC | Respiratory Virus Panel Nucleic Acid Assay System | Microbiology | Class 2 | 866.3980 | 2017-02-15 |
| JSM | Culture Media, Non-Propagating Transport | Microbiology | Class 1 | 866.2390 | 2017-02-15 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2024-12-11 |
| NQX | System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2024-12-11 |
| JSM | Culture Media, Non-Propagating Transport | Microbiology | Class 1 | 866.2390 | 2020-06-09 |
| OCC | Respiratory Virus Panel Nucleic Acid Assay System | Microbiology | Class 2 | 866.3980 | 2020-06-09 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2024-12-12 |
| OHQ | Multi-Analyte Controls Unassayed | Clinical Chemistry | Class 1 | 862.1660 | 2024-12-18 |
| OCC | Respiratory Virus Panel Nucleic Acid Assay System | Microbiology | Class 2 | 866.3980 | 2018-01-03 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2024-12-11 |
| NIJ | System, Test, Genotypic Detection, Resistant Markers, Enterococcus Species | Microbiology | Class 2 | 866.1640 | 2024-12-11 |
| OWD | Somatic Gene Mutation Detection System | Unknown | Class 3 | N/A | 2020-12-04 |
| PEU | System, Nucleic Acid-Based, Mycobacterium Tuberculosis Complex, Resistance Marker, Direct Specimen | Microbiology | Class 2 | 866.3373 | 2013-12-19 |
| NJR | Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test | Microbiology | Class 1 | 866.3740 | 2022-06-08 |
| QDC | Dna-Based Test For Minimal Residual Disease For Hematologic Malignancies | Pathology | Class 2 | 866.6100 | 2024-12-11 |
| PQA | Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System | Microbiology | Class 2 | 866.3975 | 2022-08-17 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2022-08-17 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2010-12-14 |
| NQX | System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2010-12-14 |
| OUY | Trichomonas Vaginalis Nucleic Acid Amplification Test System | Immunology | Class 2 | 866.3860 | 2024-12-11 |
| JSM | Culture Media, Non-Propagating Transport | Microbiology | Class 1 | 866.2390 | 2024-12-11 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2024-12-11 |
| NPR | Test, Factor Ii G20210a Mutations, Genomic Dna Pcr | Hematology | Class 2 | 864.7280 | 2025-05-21 |
| NPQ | Test, Factor V Leiden Mutations, Genomic Dna Pcr | Hematology | Class 2 | 864.7280 | 2025-05-21 |
| QOF | Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents | Microbiology | Class 2 | 866.3981 | 2025-05-21 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2012-12-07 |
| NJR | Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test | Microbiology | Class 1 | 866.3740 | 2012-12-07 |
| OCC | Respiratory Virus Panel Nucleic Acid Assay System | Microbiology | Class 2 | 866.3980 | 2017-02-15 |
| NIJ | System, Test, Genotypic Detection, Resistant Markers, Enterococcus Species | Microbiology | Class 2 | 866.1640 | 2010-12-14 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2010-12-14 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2023-11-02 |
| PQA | Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System | Microbiology | Class 2 | 866.3975 | 2023-11-02 |
| MMW | System, Test, Tumor Marker, Monitoring, Bladder | Immunology | Class 2 | 866.6010 | 2020-12-04 |
| NQX | System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2025-02-14 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2025-02-14 |
| PEU | System, Nucleic Acid-Based, Mycobacterium Tuberculosis Complex, Resistance Marker, Direct Specimen | Microbiology | Class 2 | 866.3373 | 2024-12-11 |
| OYX | Bcr/Abl1 Monitoring Test | Medical Genetics | Class 2 | 866.6060 | 2019-10-10 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2019-10-10 |
| PGX | Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System | Microbiology | Class 2 | 866.2680 | 2020-12-05 |
| NIA | Assay, Direct, Nucleic Acid Amplification, Influenza Virus | Microbiology | Class 1 | 866.3330 | 2020-03-04 |
| QQX | Respiratory Specimen Nucleic Acid Sars-Cov-2 Test | Microbiology | Class 2 | 866.3981 | 2023-11-10 |
| LLH | Reagents, Clostridium Difficile Toxin | Microbiology | Class 1 | 866.2660 | 2009-11-20 |
| OUY | Trichomonas Vaginalis Nucleic Acid Amplification Test System | Immunology | Class 2 | 866.3860 | 2020-03-04 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2016-11-29 |
| NQX | System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2016-11-29 |
| QTP | Reagents, Monkeypox Virus Nucleic Acid. | Unknown | Class N | N/A | 2023-02-13 |
| QJR | Reagents, 2019-Novel Coronavirus Nucleic Acid | Unknown | Class N | N/A | 2022-11-30 |
| NAH | System, Test, Tumor Marker, For Detection Of Bladder Cancer | Unknown | Class 3 | N/A | 2020-12-04 |
| SBP | Simple Point-Of-Care Nucleic Acid-Based Hepatitis C Virus Ribonucleic Acid Test | Microbiology | Class 2 | 866.3171 | 2024-07-02 |
No US Agent registered (Local establishment).
| Registration Number | Establishment Name | Location |
|---|---|---|
| 3009613136 | CEPHEID AB | SOLNA Stockholm, SE |
| 3016838963 | Cepheid | Lodi, CA, US |
| 510(k) Number | Applicant | Device Name | Decision Date |
|---|---|---|---|
| K914894 | Microtest | VIRAPURE, CHLAMYPURE AND MYCOPURE | 1991-12-18 |
| Recall ID | Recalling Firm | Recall Class | Product Description |
|---|---|---|---|
| Z-0028-2018 | Cepheid | N/A | Xpert EV Assay, Catalog GXEV-100N-10.
The Cepheid Xpert EV assay is a reverse transcription polymerase chain reaction (RT-PCR) using the GeneXpert Dx System for the presumptive qualitative detection of enterovirus (EV) RNA in cerebrospinal fluid (CSF) specimens from individuals with signs and symptoms of meningitis. |
| Z-0042-2025 | Luminex Molecular Diagnostics Inc | 2 | NxTAG Respiratory Pathogen Panel, REF: I051C0447 |
| Z-0015-2014 | Sekisui Diagnostics LLC | 1 | Product Name: OSOM C. Difficile Toxin A/B Test
Catalog Numbers: 173 (for United States) and 173 E (for Europe).
The Test is a qualitative assay (in vitro diagnostic) that employs
immunochromatographic, dipstick technology. If C. difficile toxin A or toxin B is present, a blue/gray line will appear in the test line region indicating a positive result. A red control line must appear for the results to be valid. If C. difficile toxins are not present, only the red control line will appear. An invalid test occurs when no control line appears
The Test is intended for the qualitative detection of Clostridium difficile toxins A and/or B in human stool samples. This test is intended as an aid in the diagnosis of C.difficile associated disease (CDAD) in patients with symptoms of CDAD. |
| Z-0004-2022 | Abbott Molecular, Inc. | N | Alinity m SARS-CoV-2 Amp Kit (Emergency Use Authorization, US Assay) and Alinity m SARS-CoV-2 Application Specification File. in vitro diagnostic |
| Z-0005-2022 | Abbott Molecular, Inc. | N | Alinity m Resp-4-Plex AMP Kit (Emergency Use Authorization, US Assay) and Alinity m Resp-4-Plex Application Specification File. in vitro diagnostic |
| Registration Number | Establishment Name | Location |
|---|---|---|
| 3026886124 | ROCGENE(XUZHOU) TECHNOLOGY LIMITED | Xuzhou Jiangsu, CN |
| 1524213 | MERIDIAN BIOSCIENCE, INC. | Cincinnati, OH, US |
| 3003795116 | ROCHE DIAGNOSTICS INTERNATIONAL LTD. | ROTKREUZ Zug, CH |
| 3003366417 | LRE MEDICAL GMBH | NOERDLINGEN Bavaria, DE |
| 3016619649 | Sansure Biotech Inc. | Changsha Hunan, CN |
3004530258 when referencing this establishment in official correspondence.